The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...

A man from Brighton has spoken out after the NHS agreed to offer a life-extending drug to more men with prostate cancer. Currently only those with prostate cancer that has spread can get abiraterone ...

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

Thousands of men with prostate cancer will be given a life-extending drug on the NHS, following a three-year battle to expand ...

Ghanaian-born researcher David U. Mualen, a PhD candidate in Biomedical Engineering in the United States, is gaining international recognition for research that is reshaping how modern medicines are ...

A Sri Lankan-born scientist has made waves in the global medical community with groundbreaking research that could ...

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

The first patient to receive a breakthrough treatment on the NHS for his aggressive form of leukaemia has said it was ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...